risks

The MOH is moving to distribute the drug as supply risks are reduced

by
The MOH is moving to distribute the drug as supply risks are reduced

KUALA LUMPUR, April 2 — The Ministry of Health (MOH) is tightening drug distribution in public hospitals as global cost pressures mount, even as officials say there is no immediate disruption to drug supplies. The move follows a warning by drug supplier Jardine Marketing and Distribution Sdn Bhd of supply and possible price hikes, with … Read more

A major review of GLP-1 drugs takes a closer look at the risks and rewards

by
An x-ray image of an ulnar fracture.

Moderate-to-high-quality evidence from umbrella reviews on non-cardiometabolic outcomes supported associations between GLP-1 therapy and risks of nausea, vomiting, and diarrhea. High-quality evidence indicates a possible protective association between GLP-1 medication and infection-related outcomes, particularly serious infections. Exploratory indications also suggest a possible reduction in the risk of falls, respiratory disease events, and all-cause dementia. A … Read more